Can you list some publications by Brian Malkin?
Brian Malkin has contributed significantly to the field with publications like “Companies Marketing CBD Products Be Warned: FDA Is Watching,” “New FDA Rules Put Onus On Doctors To Curb Opioid Abuse,” and “Biosimilars patent litigation in the EU and the US: a comparative strategic overview,” among others. His work spans a range of topics from CBD product marketing, opioid abuse, biosimilars patent litigation, to FDA regulatory oversight and the development of biosimilars industry in the United States.